News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
578,764 Results
Type
Article (15507)
Company Profile (152)
Press Release (563100)
Multimedia
Podcasts (16)
Webinars (12)
Section
Business (187917)
Career Advice (470)
Deals (28586)
Drug Delivery (43)
Drug Development (64756)
Employer Resources (38)
FDA (11724)
Job Trends (10470)
News (274149)
Policy (21550)
Tag
2027 BioCapital Standard (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
40 Under 40 (1)
Academia (1392)
Accelerated approval (46)
ADA (33)
Adcomms (4)
Allergies (133)
Alliances (39227)
ALS (207)
Alzheimer's disease (1424)
Antibody-drug conjugate (ADC) (501)
Approvals (12607)
Artificial intelligence (807)
ASCO (230)
Autoimmune disease (331)
Automation (61)
Bankruptcy (279)
Belgium (12)
Best Places to Work (8571)
BIO (58)
Biologics (39)
BIOSECURE Act (3)
Biosimilars (182)
BioSpace Insights (56)
Biotechnology (97)
Bispecific (16)
Bladder cancer (207)
Brain cancer (61)
Breast cancer (734)
Cancer (5737)
Cardiovascular disease (401)
Career advice (407)
Career pathing (9)
CAR-T (264)
CDC (6)
CDMO (73)
Celiac Disease (4)
Cell-line development (1)
Cell therapy (755)
Cervical cancer (46)
Clinical research (58753)
Collaboration (2092)
Commercialization (30)
Compensation (1741)
Complete response letters (43)
COVID-19 (1299)
CRISPR (106)
CRO (1)
C-suite (1206)
Cystic fibrosis (144)
Data (8792)
Decentralized trials (3)
Denatured (11)
Depression (138)
Dermatology (153)
Diabetes (533)
Diagnostics (5404)
Digital health (56)
Diversity (5)
Diversity, equity & inclusion (16)
Drug discovery (372)
Drug pricing (47)
Drug shortages (4)
Duchenne muscular dystrophy (238)
Earnings (80753)
Editorial (6)
Employer branding (3)
Employer resources (37)
Events (102713)
Executive appointments (1065)
Eye disease (7)
FDA (15609)
Fibrodysplasia Ossificans Progressiva (14)
Fragile X (2)
Friedreich's ataxia (24)
Frontotemporal dementia (33)
Funding (1637)
Gene editing (205)
Generative AI (68)
Gene therapy (582)
GLP-1 (504)
Government (1680)
Grass and pollen (4)
Guidances (355)
Healthcare (12849)
Hematology (142)
HIV (84)
Huntington's disease (45)
Idiopathic pulmonary fibrosis (9)
IgA nephropathy (100)
Immunology and inflammation (160)
Immuno-oncology (93)
Indications (237)
Infectious disease (1590)
Inflammatory bowel disease (189)
Inflation Reduction Act (7)
Influenza (127)
Intellectual property (324)
Interviews (62)
IPO (13636)
IRA (11)
Job creations (2333)
Job search strategy (366)
JPM (12)
Kidney cancer (22)
Kidney disease (94)
Labor market (11)
Layoffs (142)
Leadership (6)
Legal (5729)
Licensing (52)
Liver cancer (86)
Longevity (36)
Lung cancer (775)
Lung diease (13)
Lymphoma (412)
Machine learning (66)
Management (11)
Manufacturing (952)
Marketing (21)
MASH (166)
Medical affairs (2)
Medical device (10174)
Medtech (10394)
Mergers & acquisitions (16277)
Metabolic disorders (1095)
mRNA (133)
Multiple sclerosis (176)
Multispecific (3)
NASH (4)
Netherlands (14)
Neurodegenerative disease (390)
Neuropsychiatric disorders (60)
Neuroscience (2850)
Neurotech (2)
NextGen: Class of 2026 (4059)
Non-profit (2035)
Now hiring (9)
Obesity (368)
Opinion (119)
Ovarian cancer (237)
Pain (256)
Pancreatic cancer (327)
Parkinson's disease (329)
Partnered (25)
Patents (616)
Patient advocacy (2)
Patient recruitment (770)
Patient selection (49)
Peanut (39)
People (47557)
Peptides (19)
Pharmaceutical (31)
Pharmacy benefit managers (19)
Phase 1 (18803)
Phase 2 (25938)
Phase 3 (18188)
Pipeline (10925)
Policy (73)
Postmarket research (2023)
Preclinical (9041)
Press Release (60)
Prostate cancer (306)
Psychedelics (23)
Radioligand (1)
Radiopharmaceuticals (274)
Rare diseases (942)
Real estate (3861)
Recruiting (13)
Regenerative medicine (17)
Regulatory (18853)
Reports (28)
Research institute (1556)
Resumes & cover letters (69)
Rett syndrome (53)
RNA editing (22)
RSV (56)
Schizophrenia (157)
Series A (279)
Series B (204)
Service/supplier (6)
Sickle cell disease (101)
Special edition (2)
Spinal muscular atrophy (140)
Sponsored (32)
Startups (2519)
State (1)
Stem cells (4)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (85)
Switzerland (1)
Tariffs (9)
The Weekly (5)
Vaccines (582)
Venture capital (53)
Weight loss (134)
Wet AMD (6)
Women's health (127)
Worklife (3)
Date
Today (128)
Last 7 days (518)
Last 30 days (2101)
Last 365 days (25783)
2026 (20406)
2025 (25523)
2024 (28205)
2023 (31347)
2022 (40442)
2021 (44086)
2020 (40722)
2019 (30847)
2018 (22947)
2017 (23052)
2016 (22154)
2015 (28600)
2014 (24620)
2013 (20612)
2012 (22730)
2011 (22985)
2010 (22681)
Location
Africa (353)
Alabama (88)
Alaska (4)
Arizona (361)
Arkansas (14)
Asia (25319)
Australia (3431)
California (14775)
Canada (3785)
China (1138)
Colorado (611)
Connecticut (628)
Delaware (453)
Europe (46186)
Florida (2203)
Georgia (443)
Hawaii (4)
Idaho (47)
Illinois (1015)
India (94)
Indiana (460)
Iowa (27)
Japan (616)
Kansas (120)
Kentucky (48)
Louisiana (55)
Maine (33)
Maryland (1553)
Massachusetts (10302)
Michigan (344)
Minnesota (692)
Mississippi (4)
Missouri (118)
Montana (27)
Nebraska (16)
Nevada (173)
New Hampshire (89)
New Jersey (4246)
New Mexico (30)
New York (3722)
North Carolina (2052)
North Dakota (13)
Northern California (7644)
Ohio (408)
Oklahoma (22)
Oregon (32)
Pennsylvania (2656)
Puerto Rico (29)
Rhode Island (42)
South America (606)
South Carolina (84)
South Dakota (2)
Southern California (5957)
Tennessee (194)
Texas (2409)
United States (50858)
Utah (434)
Vermont (1)
Virginia (274)
Washington D.C. (53)
Washington State (1145)
West Virginia (2)
Wisconsin (159)
Wyoming (4)
578,764 Results for "model n inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AINN-P1: Small Model, Big Intelligence
AINN-P1: Small Model, Big IntelligenceHow does a 167M-parameter protein foundation model outperform a 650M general-purpose model on the tasks that matter?
September 10, 2026
·
1 min read
Press Releases
Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model
October 8, 2026
·
8 min read
Press Releases
DeepoMe Introduces the First Biomedical World Model for Chronic Disease Management and Aging Intervention
New preprint by Jianghui Xiong, PhD, and the DeepoMe team introduces SteeraMed, a steerable biomedical world model for N-of-1 intervention reasoning across chronic diseases and aging
May 26, 2026
·
1 min read
Press Releases
Greenstone Biosciences Selected for Wellcome Leap VISIBLE Program to Model Coronary Microvascular Disease in Women
Human iPSC-derived cardiovascular tissues, 3D computational modeling, and biofabrication will define the causal mechanisms behind a leading cause of ischemia in women
October 8, 2026
·
1 min read
Press Releases
/C O R R E C T I O N - FesariusTherapeutics, Inc/
October 13, 2026
·
3 min read
Press Releases
Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of Directors
October 13, 2026
·
3 min read
Press Releases
Ainnocence Shows AINN-P1 Protein Foundation Model Improves Antibody-Antigen Affinity Ranking by 28% - From Sequence Alone
Ainnocence’s foundation model trained from scratch, requiring no structure, no multiple sequence alignment, no fine-tuning, training in hours rather than weeks.
August 27, 2026
·
1 min read
Press Releases
American Chemical Society CRT | Model Medicines Publishes Class-Leading, Regulatory Grade Toxicology Model AmesNet™, Validation of GALILEO™ Platform & ChemPrint™ Model Underpinning Drug Pipeline
AmesNet’s Task-Conditioned Learning architecture outperforms FDA, MIT, Tencent, and the University of Sydney models in both sensitivity and balanced accuracy on out-of-domain chemical data on a public dataset; AmesNet is built on top of ChemPrint, the core and proprietary deep-learning engine of the GALILEO platform that powers the company’s drug pipeline.
June 30, 2026
·
1 min read
Press Releases
AvantGuard Outperforms Chlorhexidine in Candida auris Skin Decolonization Mouse Model
October 13, 2026
·
2 min read
Press Releases
Vantis Vascular Receives FDA Clearance for 6F CrossFAST Model
October 14, 2026
·
3 min read
1 of 57,877
Next